TMS Co., Ltd Logo

TMS Co., Ltd

4891 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
府中市府中町一丁目9番地京王府中1丁目ビル11階
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TMS Co., Ltd is a Japanese company focused on enhancing user experiences through advanced technology solutions. Leveraging innovative digital tools, TMS is dedicated to providing seamless browsing experiences for its clients and visitors. The company emphasizes the importance of user consent and data privacy, implementing cookie policies that ensure transparency in its digital engagements. TMS Co., Ltd strives to maintain high standards of service while adapting to the evolving landscape of technology, aiming to meet the diverse needs of its users effectively. With a commitment to quality and user satisfaction, TMS continues to be a significant player in the tech industry.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TMS Co., Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-30 03:20
Regulatory News Service
臨時報告書
Japanese 27.5 KB
2025-05-30 03:18
Regulatory News Service
確認書
Japanese 7.9 KB
2025-05-30 03:17
Regulatory News Service
内部統制報告書-第21期(2024/03/01-2025/02/28)
Japanese 21.1 KB
2025-05-30 03:15
Annual Report
有価証券報告書-第21期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-04-09 09:05
Regulatory News Service
臨時報告書
Japanese 19.9 KB
2025-03-14 07:58
Prospectus
有価証券届出書(組込方式)
Japanese 407.4 KB
2025-02-28 07:37
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2025-02-06 09:01
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2024-10-15 08:18
Regulatory News Service
確認書
Japanese 7.9 KB
2024-10-15 08:15
Interim Report
半期報告書-第21期(2024/03/01-2025/02/28)
Japanese 176.1 KB
2024-07-12 08:14
Regulatory News Service
確認書
Japanese 7.9 KB
2024-07-12 08:12
Quarterly Report
四半期報告書-第21期第1四半期(2024/03/01-2024/05/31)
Japanese 125.8 KB
2024-05-29 03:27
Regulatory News Service
確認書
Japanese 7.9 KB
2024-05-29 03:25
Regulatory News Service
内部統制報告書-第20期(2023/03/01-2024/02/29)
Japanese 21.1 KB
2024-05-29 03:23
Annual Report
有価証券報告書-第20期(2023/03/01-2024/02/29)
Japanese 2.8 MB

Automate Your Workflow. Get a real-time feed of all TMS Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TMS Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Basilea Pharmaceutica AG Logo
Develops and commercializes anti-infective drugs for severe bacterial and fungal infections.
Switzerland BSLN
Bavarian Nordic Logo
A biotech firm developing and manufacturing life-saving vaccines for travel and public health.
Denmark BAVA
Bayer AG Logo
A life science company in healthcare and agriculture, offering pharmaceuticals, self-care, and crop tech.
Germany BAY
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
Bioceltix S.A. Logo
Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.
Poland BCX
Biofarm S.A. Logo
Romanian pharma firm producing OTCs & therapeutic solutions for domestic & export markets.
Romania BIO
Biofrontera AG Logo
Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.
Germany B8F
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden BIOG
Bio-Gate AG Logo
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
Germany BIG1
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden BINV